ArticleNature communications2026
DDA-BERT: end-to-end training for data-dependent acquisition mass spectrometry-based proteomics.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DDA-BERT: end-to-end training for data-dependent acquisition mass spectrometry-based proteomics.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Peptide-spectrum match (PSM) rescoring is critical for accurate peptide identification in data-dependent acquisition (DDA)-based proteomics. Existing rescoring frameworks typically combine search-engine scores with heuristic or learned auxiliary features to refine PSM ranking and confidence estimation. Although recent approaches incorporate deep learning-derived representations of spectra, retention time, or ion mobility, the final decision stage still commonly relies on separately trained shallow classifiers, constraining the expressive capacity of the overall scoring framework. Here, we introduce DDA-BERT, a transformer-based end-to-end deep learning model trained with ~271 million PSMs from 11 species. DDA-BERT consistently outperforms existing tools across species-specific benchmarks, achieving 2.24%-269.35%, 3.73%-141.46%, 5.53%-45.64%, and 3.68%-62.77% increases in peptide identifications on human, yeast, Drosophila, and Arabidopsis datasets, respectively. The model retains high sensitivity in trace-level proteomics samples. On HLA immunopeptidomics data, DDA-BERT further increases peptide identifications by 4.14%-87.47%. The main limitations of DDA-BERT include the requirement for GPU-based computing and the need for substantial, diverse training datasets to achieve optimal model performance. This study introduces an alternative DDA rescoring approach and establishes a methodological foundation for scalable, AI-driven peptide identification in DDA proteomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.